yep its been a complete failure - raising so soon after IPONo credibility in the company now. Claims of Q4 break even.so both Neil & mine calls were 100% right after all.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%